Citation Impact
Citing Papers
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
2017 Standout
Major depressive disorder
2016 Standout
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
N-methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRI
2016
Human pharmacological MRI
2004
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
2010
Self-referential processing in our brain—A meta-analysis of imaging studies on the self
2006 Standout
Reciprocal modulation and attenuation in the prefrontal cortex: An fMRI study on emotional–cognitive interaction
2004
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
2016 Standout
Psychedelics
2016 Standout
Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients
2005
Cognitive impairment in depression: a systematic review and meta-analysis
2013
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
The role of the posterior cingulate cortex in cognition and disease
2013 Standout
Glutamate and the Neural Basis of the Subjective Effects of Ketamine
2008
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
2010 Standout
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences
2020 Standout
A meta-analytic review of emotion recognition and aging: Implications for neuropsychological models of aging
2008 Standout
The acute effects of NMDA antagonism: From the rodent to the human brain
2008
Tripping on nothing: placebo psychedelics and contextual factors
2020 Standout
Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis
2008
Efficiency and Cost of Economical Brain Functional Networks
2007 Standout
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
2016 Standout
Works of André Richter being referenced
Sustained Cognitive Impairments After Clinical Recovery of Severe Depression
2012
NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI
2004
GABA-ergic Modulation of Prefrontal Spatio-temporal Activation Pattern during Emotional Processing: A Combined fMRI/MEG Study with Placebo and Lorazepam
2002